No abstract available
MeSH terms
-
2019-nCoV Vaccine mRNA-1273
-
Ad26COVS1
-
Asymptomatic Diseases
-
BNT162 Vaccine
-
COVID-19 / prevention & control*
-
COVID-19 / transmission
-
COVID-19 Vaccines / administration & dosage
-
COVID-19 Vaccines / immunology*
-
Communicable Disease Control / methods
-
Disease Transmission, Infectious / prevention & control*
-
Drug Approval
-
Global Health
-
Humans
-
Immunization, Secondary*
-
Immunogenicity, Vaccine*
-
Israel
-
Risk Assessment
-
United States
-
United States Food and Drug Administration
Substances
-
Ad26COVS1
-
COVID-19 Vaccines
-
2019-nCoV Vaccine mRNA-1273
-
BNT162 Vaccine